🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate if offering long-acting injectable...
Status
Not Yet Recruiting
Location
Hôpital Hôtel Dieu
Start Date
2024-04-01
Trial ID
NCT06273943
The purpose of this study was to evaluate the pharmacokinetic (PK) properti...
Status
Terminated
Location
Usc La Nichd Crs
Start Date
2021-09-01
Trial ID
NCT04518228
Treatments Being Tested
The study is designed to select a dose of GSK1265744 primarily on the basis...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-08-06
Trial ID
NCT01641809
This is a phase 1, open label study in healthy participants to assess the p...
Status
Completed
Location
GSK Investigational Site
Start Date
2020-09-16
Trial ID
NCT04371380
This open-label, fixed-sequence crossover study aims to evaluate the effect...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-08
Trial ID
NCT02159131
Treatments Being Tested
To evaluate the single dose relative bioavailability of GSK1265744 10mg adm...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-06
Trial ID
NCT00812318
Treatments Being Tested
Cabotegravir is being developed for the treatment of human immunodeficiency...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06
Trial ID
NCT02799264
Treatments Being Tested